SCHEMBL5226833

SCHEMBL5226833

Cc1cc(F)ccc1-c1nc(S(C)(=O)=O)nc2c1CNC(=O)N2C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 3/20 0.42
PTGS2 P35354 1/20 0.34
ABL1 P00519 3/20 0.33
CNR2 P34972 1/20 0.33
FABP1 P07148 1/20 0.33
EPHX2 P34913 1/20 0.32
PDE4A P27815 1/20 0.31
TGFBR1 P36897 1/20 0.31
TLR8 Q9NR97 1/20 0.31
BRD4 O60885 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRL1 P41146 1/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPK1 P28482 1/20 0.31
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223605 0.84 HSP90AB1 (0.43) MAPK14CNR2PDE4AOPRM1OPRL1
SCHEMBL5225622 0.80 MAPK14 (0.38) MAPK14ALDH1A1MAPK1MEN1STAT3
SCHEMBL5225468 0.79 MAPK14 (0.60) MAPK14FABP1
SCHEMBL5229775 0.79 MAPK14 (0.41) MAPK14TLR8BRD4
SCHEMBL5230882 0.79 ALDH1A1 (0.33) MAPK14ABL1ALDH1A1MAPK1MEN1
SCHEMBL5227756 0.79 MAPK14 (0.54) MAPK14PTGS2FABP1
SCHEMBL3282205 0.79 MAPK14 (0.59) MAPK14FABP1
SCHEMBL5229428 0.78 MAPK14 (0.38) MAPK14ALDH1A1MAPK1MEN1KMT2A
SCHEMBL5230029 0.78 RPS6KA6 (0.31) MAPK14PDE4AALDH1A1STAT3SMN1; SMN2
SCHEMBL5231774 0.78 ALDH1A1 (0.35) MAPK14ALDH1A1MAPK1MEN1STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1842851-A2 Novel compounds Smithkline Beecham Corporation (US) 2007-10-10 EP disclosed
EP-1265900-B1 1,5-DISUBSTITUTED-3,4-DIHYDRO-1H-PYRIMIDO 4,5-D|PYRIMIDIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CSBP/P38 KINASE MEDIATED DISEASES SMITHKLINE BEECHAM CORP (US) 2007-05-16 EP disclosed